Vaccines, diagnostics and biology of the livestock morbilliviruses rinderpest virus and peste des petits ruminants virus
Lead Research Organisation:
THE PIRBRIGHT INSTITUTE
Department Name: UNLISTED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
Peste des petits ruminants virus (PPRV) is a morbillivirus, closely related to the human pathogen Measles virus (MV) and Rinderpest virus (RPV), the recently eradicated cause of a devastating disease of cattle. PPR is a rapidly spreading disease of sheep and goats, widespread now in large parts of the developing world. Since these animals are most commonly the primary livestock of people at the bottom end of the economic ladder, the socio-economic impact of PPR outbreaks tends to be particularly hard on these groups, and there is a growing movement to control and eventually eradicate PPR. IAH played a significant role in the eradication of RPV, including training, diagnostic development and understanding the biology of the virus. This project aims to make a similar contribution to the global effort against PPRV.
On the applied side, we are developing new vaccines against PPR which will allow the distinguishing of infected and vaccinated animals (DIVA vaccines), as well as pen-side tests to allow more rapid identification of PPRV infection. A significant part of this work involves collaboration with laboratories in Africa to uplift their capabilities. We are working in the laboratory on generating recombinant antigen for diagnostic tests, to eliminate the need for growing live virus. We are also studying the molecular and cell biology of the virus, examining the way it controls host innate immune responses. We have developed a system for recovering live virus from a DNA copy of the genome, allowing us to create targeted mutations in the virus, and will apply this technique to studies of the growth of the virus and the biology underlying the restriction of disease to sheep and goats.
On the applied side, we are developing new vaccines against PPR which will allow the distinguishing of infected and vaccinated animals (DIVA vaccines), as well as pen-side tests to allow more rapid identification of PPRV infection. A significant part of this work involves collaboration with laboratories in Africa to uplift their capabilities. We are working in the laboratory on generating recombinant antigen for diagnostic tests, to eliminate the need for growing live virus. We are also studying the molecular and cell biology of the virus, examining the way it controls host innate immune responses. We have developed a system for recovering live virus from a DNA copy of the genome, allowing us to create targeted mutations in the virus, and will apply this technique to studies of the growth of the virus and the biology underlying the restriction of disease to sheep and goats.
Planned Impact
unavailable
Organisations
People |
ORCID iD |
| Michael Baron (Principal Investigator) |
Publications
Baron J
(2014)
Early changes in cytokine expression in peste des petits ruminants disease.
in Veterinary research
Baron J
(2015)
Development of a helper cell-dependent form of peste des petits ruminants virus: a system for making biosafe antigen.
in Veterinary research
Baron J
(2014)
Development and testing of a field diagnostic assay for peste des petits ruminants virus.
in Transboundary and emerging diseases
Baron M
(2015)
Peste des Petits Ruminants Virus
Baron MD
(2016)
Peste des Petits Ruminants Virus.
in Advances in virus research
Chinnakannan SK
(2013)
Morbillivirus v proteins exhibit multiple mechanisms to block type 1 and type 2 interferon signalling pathways.
in PloS one
Chinnakannan SK
(2014)
Different functions of the common P/V/W and V-specific domains of rinderpest virus V protein in blocking IFN signalling.
in The Journal of general virology
Holzer B
(2016)
Protection of Cattle against Rinderpest by Vaccination with Wild-Type but Not Attenuated Strains of Peste des Petits Ruminants Virus
in Journal of Virology
| Description | PPR is a small ruminant disease of growing global importance. We have developed a coherent method of generating the disease in captive animals, allowing to begin the study of the pathology of the virus as well as enabling us to make definitive assays of the effectiveness of novel and existing vaccines. We have developed an entirely helper-cell dependent form of PPRV, which will allow the creation of non-replicating forms of the virus that can be safely handled outside of the containment laboratory. Project is ongoing. |
| Exploitation Route | This should wait until the project is closer to completion. |
| Sectors | Agriculture Food and Drink |
| Description | We are developing a contract with a commercial company to license the helper-cell dependent virus system to create a diagnostic ELISA. |
| First Year Of Impact | 2014 |
| Sector | Agriculture, Food and Drink |
| Impact Types | Economic |
| Description | Work for OIE on PPR control |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Input to development of global disease policy for PPR as a livestock disease. This has now become polcy for all countries that are members of the OIE (World Organisation for Animal Health) |
| Description | work for FAO on rinderpest sequestration |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Responsive grant |
| Amount | £173,000 (GBP) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 09/2013 |
| End | 09/2017 |
| Description | Sequencing and destruction of rinderpest virus isolates |
| Amount | £178,124 (GBP) |
| Organisation | World Organisation for Animal Health, France |
| Sector | Public |
| Country | France |
| Start | 03/2016 |
| End | 03/2018 |
| Description | Sub-contract |
| Amount | £485,430 (GBP) |
| Organisation | World Organisation for Animal Health, France |
| Sector | Public |
| Country | France |
| Start | 09/2012 |
| End | 10/2015 |
| Title | Challenge system for peste des petits ruminants virus |
| Description | Technique developed to give reproducible disease outcome in UK goats on infection with peste des petits ruminants virus (PPRV), allowing controlled testing of vaccines |
| Type Of Material | Technology assay or reagent |
| Year Produced | 2013 |
| Provided To Others? | Yes |
| Impact | This system has allowed us to reproducibly and appropriately test new vaccines against PPRV as well as assess the effectiveness of existing vaccines. Several papers have been published. |
| Title | field diagnostic test for PPR |
| Description | Diagnostic test for the sheep/goat disease PPR. This test is now being sold to global groups involved in the world-wide eradication program for PPR. |
| Type | Diagnostic Tool - Non-Imaging |
| Current Stage Of Development | Small-scale adoption |
| Year Development Stage Completed | 2014 |
| Development Status | Under active development/distribution |
| Impact | Increased awareness of the roles of correct diagnosis in disease control. |